About
Genase Therapeutics develops small molecule inhibitors targeting metabolic vulnerabilities in oncogene-addicted cancers, aiming to replace 5-fluorouracil with a superior alternative for patients with DPD deficiency.
Explore Genase Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.